EW logo

EW
Edwards Lifesciences Corp

4,917
Mkt Cap
$50.32B
Volume
1.27M
52W High
$87.89
52W Low
$65.94
PE Ratio
35.86
EW Fundamentals
Price
$83.19
Prev Close
$84.24
Open
$84.90
50D MA
$81.29
Beta
0.75
Avg. Volume
3.78M
EPS (Annual)
$1.46
P/B
4.79
Rev/Employee
$344,272.15
Loading...
Loading...
News
all
press releases
Edwards Lifesciences (NYSE:EW) VP Sells 11,340 Shares
Edwards Lifesciences Corporation (NYSE:EW - Get Free Report) VP Donald Bobo, Jr. sold 11,340 shares of Edwards Lifesciences stock in a transaction on Wednesday, December 10th. The shares were sold at...
MarketBeat·20h ago
News Placeholder
More News
News Placeholder
Edwards Lifesciences Corporation $EW Shares Sold by Glenview Trust co
Glenview Trust co trimmed its position in Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 14.9% in the second quarter, according to its most recent disclosure with the Securities and...
MarketBeat·1d ago
News Placeholder
Should You Continue to Hold EW Stock in Your Portfolio?
Edwards Lifesciences leans on growth in Surgical Structural Heart, TAVR and TMTT, though macro pressures and litigation continue to weigh on margins.
Zacks·1d ago
News Placeholder
State Street Corp Cuts Stock Position in Edwards Lifesciences Corporation $EW
State Street Corp lessened its position in shares of Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 0.6% in the 2nd quarter, according to the company in its most recent 13F filing with...
MarketBeat·1d ago
News Placeholder
Daiwa Securities Group Inc. Acquires 24,475 Shares of Edwards Lifesciences Corporation $EW
Daiwa Securities Group Inc. boosted its holdings in shares of Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 21.2% during the 2nd quarter, according to the company in its most recent...
MarketBeat·1d ago
News Placeholder
Bank of Nova Scotia Grows Stock Holdings in Edwards Lifesciences Corporation $EW
Bank of Nova Scotia grew its position in Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 14.6% in the second quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·1d ago
News Placeholder
Edwards Lifesciences (NYSE:EW) CFO Sells $650,419.00 in Stock
Edwards Lifesciences Corporation (NYSE:EW - Get Free Report) CFO Scott Ullem sold 7,700 shares of the business's stock in a transaction dated Tuesday, December 9th. The shares were sold at an average...
MarketBeat·2d ago
News Placeholder
Axa S.A. Boosts Stock Holdings in Edwards Lifesciences Corporation $EW
Axa S.A. increased its position in Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 11.1% in the second quarter, according to the company in its most recent filing with the Securities...
MarketBeat·2d ago
News Placeholder
Scott Ullem Sells 7,700 Shares of Edwards Lifesciences (NYSE:EW) Stock
Edwards Lifesciences Corporation (NYSE:EW - Get Free Report) CFO Scott Ullem sold 7,700 shares of the firm's stock in a transaction that occurred on Tuesday, December 9th. The shares were sold at an...
MarketBeat·3d ago
News Placeholder
Vega Investment Solutions Has $28,000 Stock Holdings in Edwards Lifesciences Corporation $EW
Vega Investment Solutions lowered its position in Edwards Lifesciences Corporation (NYSE:EW - Free Report) by 98.1% in the second quarter, according to the company in its most recent 13F filing with...
MarketBeat·3d ago

Latest EW News

View

Advertisement|Remove ads.

Advertisement|Remove ads.